Cargando…
STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes
BACKGROUND: Leukostasis is a key patho-physiological event responsible for capillary occlusion in diabetic retinopathy. Circulating monocytes are the main cell type entrapped in retinal vessels in diabetes. In this study, we investigated the role of the signal transducer and activator of transcripti...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615157/ https://www.ncbi.nlm.nih.gov/pubmed/31286987 http://dx.doi.org/10.1186/s12974-019-1533-1 |
_version_ | 1783433310412734464 |
---|---|
author | Chen, Mei Obasanmi, Gideon Armstrong, David Lavery, Nuala-Jane Kissenpfennig, Adrien Lois, Noemi Xu, Heping |
author_facet | Chen, Mei Obasanmi, Gideon Armstrong, David Lavery, Nuala-Jane Kissenpfennig, Adrien Lois, Noemi Xu, Heping |
author_sort | Chen, Mei |
collection | PubMed |
description | BACKGROUND: Leukostasis is a key patho-physiological event responsible for capillary occlusion in diabetic retinopathy. Circulating monocytes are the main cell type entrapped in retinal vessels in diabetes. In this study, we investigated the role of the signal transducer and activator of transcription 3 (STAT3) pathway in diabetes-induced immune cell activation and its contribution to retinal microvascular degeneration. METHODS: Forty-one patients with type 1 diabetes (T1D) [mild non-proliferative diabetic retinopathy (mNPDR) (n = 13), active proliferative DR (aPDR) (n = 14), inactive PDR (iPDR) (n = 14)] and 13 age- and gender-matched healthy controls were recruited to the study. C57BL/6 J WT mice, SOCS3(fl/fl) and LysM(Cre/+)SOCS3(fl/fl) mice were rendered diabetic by Streptozotocin injection. The expression of the phosphorylated human and mouse STAT3 (pSTAT3), mouse LFA-1, CD62L, CD11b and MHC-II in circulating immune cells was evaluated by flow cytometry. The expression of suppressor of cytokine signalling 3 (SOCS3) was examined by real-time RT-PCR. Mouse plasma levels of cytokines were measured by Cytometric Beads Array assay. Retinal leukostasis was examined following FITC-Concanavalin A perfusion and acellular capillary was examined following Isolectin B4 and Collagen IV staining. RESULTS: Compared to healthy controls, the expression of pSTAT3 in circulating leukocytes was statistically significantly higher in mNPDR but not aPDR and was negatively correlated with diabetes duration. The expression of pSTAT3 and its inhibitor SOCS3 was also significantly increased in leukocytes from diabetic mice. Diabetic mice had higher plasma levels of IL6 and CCL2 compared with control mice. LysM(Cre/+)SOCS3(fl/fl) mice and SOCS3(fl/fl) mice developed comparative levels of diabetes, but leukocyte activation, retinal leukostasis and number of acellular capillaries were statistically significantly increased in LysM(Cre/+)SOCS3(fl/fl) diabetic mice. CONCLUSION: STAT3 activation in circulating immune cells appears to contribute to retinal microvascular degeneration and may be involved in DR initiation in T1D. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-019-1533-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6615157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66151572019-07-18 STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes Chen, Mei Obasanmi, Gideon Armstrong, David Lavery, Nuala-Jane Kissenpfennig, Adrien Lois, Noemi Xu, Heping J Neuroinflammation Research BACKGROUND: Leukostasis is a key patho-physiological event responsible for capillary occlusion in diabetic retinopathy. Circulating monocytes are the main cell type entrapped in retinal vessels in diabetes. In this study, we investigated the role of the signal transducer and activator of transcription 3 (STAT3) pathway in diabetes-induced immune cell activation and its contribution to retinal microvascular degeneration. METHODS: Forty-one patients with type 1 diabetes (T1D) [mild non-proliferative diabetic retinopathy (mNPDR) (n = 13), active proliferative DR (aPDR) (n = 14), inactive PDR (iPDR) (n = 14)] and 13 age- and gender-matched healthy controls were recruited to the study. C57BL/6 J WT mice, SOCS3(fl/fl) and LysM(Cre/+)SOCS3(fl/fl) mice were rendered diabetic by Streptozotocin injection. The expression of the phosphorylated human and mouse STAT3 (pSTAT3), mouse LFA-1, CD62L, CD11b and MHC-II in circulating immune cells was evaluated by flow cytometry. The expression of suppressor of cytokine signalling 3 (SOCS3) was examined by real-time RT-PCR. Mouse plasma levels of cytokines were measured by Cytometric Beads Array assay. Retinal leukostasis was examined following FITC-Concanavalin A perfusion and acellular capillary was examined following Isolectin B4 and Collagen IV staining. RESULTS: Compared to healthy controls, the expression of pSTAT3 in circulating leukocytes was statistically significantly higher in mNPDR but not aPDR and was negatively correlated with diabetes duration. The expression of pSTAT3 and its inhibitor SOCS3 was also significantly increased in leukocytes from diabetic mice. Diabetic mice had higher plasma levels of IL6 and CCL2 compared with control mice. LysM(Cre/+)SOCS3(fl/fl) mice and SOCS3(fl/fl) mice developed comparative levels of diabetes, but leukocyte activation, retinal leukostasis and number of acellular capillaries were statistically significantly increased in LysM(Cre/+)SOCS3(fl/fl) diabetic mice. CONCLUSION: STAT3 activation in circulating immune cells appears to contribute to retinal microvascular degeneration and may be involved in DR initiation in T1D. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-019-1533-1) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-08 /pmc/articles/PMC6615157/ /pubmed/31286987 http://dx.doi.org/10.1186/s12974-019-1533-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Chen, Mei Obasanmi, Gideon Armstrong, David Lavery, Nuala-Jane Kissenpfennig, Adrien Lois, Noemi Xu, Heping STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes |
title | STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes |
title_full | STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes |
title_fullStr | STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes |
title_full_unstemmed | STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes |
title_short | STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes |
title_sort | stat3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615157/ https://www.ncbi.nlm.nih.gov/pubmed/31286987 http://dx.doi.org/10.1186/s12974-019-1533-1 |
work_keys_str_mv | AT chenmei stat3activationincirculatingmyeloidderivedcellscontributestoretinalmicrovasculardysfunctionindiabetes AT obasanmigideon stat3activationincirculatingmyeloidderivedcellscontributestoretinalmicrovasculardysfunctionindiabetes AT armstrongdavid stat3activationincirculatingmyeloidderivedcellscontributestoretinalmicrovasculardysfunctionindiabetes AT laverynualajane stat3activationincirculatingmyeloidderivedcellscontributestoretinalmicrovasculardysfunctionindiabetes AT kissenpfennigadrien stat3activationincirculatingmyeloidderivedcellscontributestoretinalmicrovasculardysfunctionindiabetes AT loisnoemi stat3activationincirculatingmyeloidderivedcellscontributestoretinalmicrovasculardysfunctionindiabetes AT xuheping stat3activationincirculatingmyeloidderivedcellscontributestoretinalmicrovasculardysfunctionindiabetes |